What are Anti-TPO Antibodies?
Anti-thyroid peroxidase (anti-TPO) antibodies are autoantibodies directed against thyroid peroxidase, a key enzyme in thyroid hormone synthesis, and serve as the primary serologic marker for autoimmune thyroid disease, particularly Hashimoto's thyroiditis. 1
Definition and Biological Basis
Anti-TPO antibodies (also historically known as anti-microsomal antibodies) are IgG-class autoantibodies that target thyroid peroxidase (TPO), the enzyme responsible for catalyzing iodine oxidation and incorporation into thyroglobulin during thyroid hormone production 2. These antibodies recognize conformationally intact TPO, specifically targeting an immunodominant region comprising overlapping A and B domains on the enzyme 2.
The presence of anti-TPO antibodies indicates thyroid autoimmunity and reflects an inherited defect in immune surveillance, leading to abnormal immune regulation and thyroid gland infiltration by sensitized T lymphocytes 1.
Clinical Significance and Prevalence
In the General Population
- Anti-TPO antibodies are present in 11.3% of the disease-free population according to the NHANES survey 1
- They are more common in women than men and increase with age 1
- Among patients with chronic autoimmune thyroiditis, approximately 75% have elevated anti-thyroid antibody titers 1
Diagnostic Utility
Anti-TPO antibodies are the single most clinically useful thyroid autoantibody because only positive TPOAb tests are significantly associated with hypothyroidism 1. This distinguishes them from anti-thyroglobulin antibodies, which have less predictive value.
The antibodies serve multiple diagnostic purposes:
- Identifying autoimmune thyroiditis in patients with diffuse, firm goiter or documented hypothyroidism 1
- Distinguishing autoimmune thyroiditis from non-immunologic multinodular goiter, which rarely progresses to hypothyroidism 1
- Assessing thyroid autoimmunity when anti-TSH receptor antibodies are negative in suspected Graves' disease 3
Prognostic Value
The most critical clinical application of anti-TPO antibodies is predicting progression from subclinical to overt hypothyroidism:
- 4.3% annual progression rate in TPOAb-positive patients
- 2.6% annual progression rate in TPOAb-negative patients 1, 4
This nearly doubled risk of progression is why professional societies and clinical endocrinologists endorse measuring TPOAb in patients with subclinical hypothyroidism 1.
Additional Prognostic Applications
Anti-TPO antibodies help predict thyroid dysfunction risk in:
- Pregnant women: predicting first-trimester hypothyroidism and postpartum thyroid dysfunction 5
- Patients on specific medications: lithium, interferon-alpha, amiodarone 1
- Patients with other autoimmune diseases: type 1 diabetes, Addison's disease 1, 6
- Chromosomal disorders: Down syndrome, Turner syndrome 1
Pathophysiology
There is a strong correlation between anti-TPO antibody titers and the degree of lymphocytic infiltration in the thyroid gland 5, 7. Even within the normal TSH range, TPO antibody titers correlate with TSH levels, suggesting their presence heralds impending thyroid failure 5.
Once present, these antibodies generally persist, with spontaneous disappearance occurring infrequently 1. The antibodies develop in response to TPO presented by thyroid cells themselves, rather than to TPO released by damaged thyrocytes 2.
Clinical Testing Considerations
Modern assays use highly sensitive radioimmunoassays or enzyme immunoassays 7. However, despite calibration against the same MRC standard 66/387, there is wide variation in results between techniques, with positivity thresholds ranging from 4 to 120 IU/L 3.
Important Caveat
Very low titers of anti-TPO antibodies can be found in virtually all subjects with modern sensitive assays, but only titers above an assay-dependent cut-off represent a clear risk factor for hypothyroidism 5.
Association with Inflammation
Recent evidence demonstrates that anti-TPO positivity is associated with elevated high-sensitivity C-reactive protein (hsCRP), indicating a systemic inflammatory state beyond thyroid-specific autoimmunity 8. Anti-TPO-positive patients show higher prevalence of fatigue, cold intolerance, and lipid abnormalities 8.